Authors/Disclosures
|
Edwin Trevathan, MD, MPH, FAAN
(Vanderbilt University Medical Center)
|
Dr. Trevathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Trevathan has received research support from NINDS/NIH. |
|
Richard S. Isaacson, MD, FAAN
|
Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care. |
|
Susan Kerls
(GlaxoSmithKline)
|
No disclosure on file |
|
Emily Caesar
|
No disclosure on file |
|
Anne E. Hammer
(Glaxo Welcome)
|
No disclosure on file |
|
|
No disclosure on file |
|
Alain Vuong
(GlaxoSmithKline)
|
No disclosure on file |
|
Syed S. Ali, MD
(Tri City Neurology Associates Ltd.)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
John A. Messenheimer, Jr., MD
|
Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Lisa Mosconi
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Matthew W. Schelke, MD
(New York Presbyterian Hospital, Columbia)
|
Dr. Schelke has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Alon Seifan, MD
(Cognitive Neurology Consultants, Inc. dba the Neuro Well)
|
Dr. Seifan has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Science Officer with HB Biotech. |